ZB
ASND icon

Zions Bancorporation’s Ascendis Pharma A/S ASND Stock Holding History

Zions Bancorporation’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-39
Closed -$4.76K – 917
2022
Q4 		$4.76K Buy
+39
New +$4.53K ﹤0.01% 861

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Zions Bancorporation's ASND Position: Q1 2023 in Review

Zions Bancorporation sold out of Ascendis Pharma A/S (ASND) in Q1 2023, closing a stake of 39 shares — an estimated $4.76K sold.

Zions Bancorporation first reported a position in ASND in Q4 2022 and held it in 1 quarter. The position peaked at $4.76K in Q4 2022. 164 funds tracked by Wall St. Rank hold ASND as of Q1 2023.

  • Zions Bancorporation reported no remaining Ascendis Pharma A/S position as of Q1 2023 after selling out during the quarter.
  • Zions Bancorporation sold 39 Ascendis Pharma A/S shares in Q1 2023, an estimated $4.76K.
  • Zions Bancorporation first reported a position in Ascendis Pharma A/S in Q4 2022 and held it in 1 quarter.
  • Zions Bancorporation's Ascendis Pharma A/S position peaked at $4.76K in Q4 2022.
  • 164 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2023.

Based on Zions Bancorporation's 13F filing for Q1 2023, filed 10 May 2023.